每经AI快讯，迈得医疗（SH 688310，收盘价：14.78元）12月18日晚间发布公告称，迈得医疗工业设备 股份有限公司于2025年12月11日召开第五届董事会第八次会议，审议通过了《关于以集中竞价交易方式 回购公司股份方案的议案》。现将公司2025年12月12日前十大无限售条件股东披露如下：林军华持约 7837万股，占比47.15%；陈万顺持约2475万股，占比14.89%；台州赛纳投资咨询合伙企业（有限合 伙）持约573万股，占比3.45%；迈得医疗工业设备股份有限公司回购专用证券账户持约259万股，占比 1.56%；申万菱信基金－光大银行－申万菱信常鸿1号集合资产管理计划持约155万股，占比0.93%；王 俏丽持约130万股，占比0.78%；张鹏持约119万股，占比0.72%；涂筱莲持约103万股，占比0.62%；张 海持约102万股，占比0.61%；中国建设银行股份有限公司－交银施罗德稳健配置混合型证券投资基金 持约96万股，占比0.58%。前十大流通股东合计持股约1.19亿股，占比71.29%。 2024年1至12月份，迈得医疗的营业收入构成为：专用设备制造业占比98.7%，其他业务占比1.3% ...

证券代码：688310 证券简称：迈得医疗 公告编号：2025-053 一、公司前十大股东持股情况 | 7 | 张鹏 | 1,189,804 | 0.72 | | --- | --- | --- | --- | | 8 | 涂筱莲 | 1,029,682 | 0.62 | | 9 | 张海 | 1,018,202 | 0.61 | | 10 | 中国建设银行股份有限公司－交银施罗德稳 | 963,771 | 0.58 | | | 健配置混合型证券投资基金 | | | 二、公司前十大无限售条件股东持股情况 | 序号 | 持有人名称 | 持股数量 | 占总股本比例 | | --- | --- | --- | --- | | | | （股） | （%） | | 1 | 林军华 | 78,372,560 | 47.15 | | 2 | 陈万顺 | 24,754,800 | 14.89 | | 3 | 台州赛纳投资咨询合伙企业（有限合伙） | 5,727,120 | 3.45 | | 4 | 迈得医疗工业设备股份有限公司回购专用证 | 2,592,575 | 1.56 | | | 券账户 | | | | 5 | 申万菱 ...

（文章来源：证券日报） 证券日报网讯 12月15日，迈得医疗在互动平台回答投资者提问时表示，公司已于2025年12月11日召开 董事会，会议审议并通过《关于以集中竞价交易方式回购公司股份方案的议案》等议案，具体内容详见 公司于12月13日披露在上海证券交易所网站的《迈得医疗工业设备股份有限公司关于以集中竞价交易方 式回购股份的预案》（公告编号：2025-051）和《迈得医疗工业设备股份有限公司第五届董事会第八次 会议决议公告》（公告编号：2025-050）。 ...

证券日报网讯12月15日，迈得医疗在互动平台回答投资者提问时表示，公司目前处于正常经营状态。公 司隐形眼镜业务商业化尚处于起步阶段，收入对公司业绩尚未产生重大影响。且公司目前正在申请佩戴 周期为日抛的软性亲水接触镜注册证照。 ...

有投资者在投资者互动平台向 迈得医疗公司提问：1.贵公司近期下跌幅度远高于行业平均水平，是否经 营正常？2.隐形眼镜，上市后销售情况如何？3.日抛取证，预计什么时候有结论？ 迈得医疗回复称，公 司目前处于正常经营状态。公司隐形眼镜业务商业化尚处于起步阶段，收入对公司业绩尚未产生重大影 响。且公司目前正在申请佩戴周期为日抛的软性亲水接触镜注册证照。 ...

Group 1: Company Announcements - Yongding Co., Ltd. does not directly manufacture controllable nuclear fusion devices but provides materials for the winding magnets of such devices [1] - Aerospace Power's main business does not involve commercial aerospace, nor does it have any commercial aerospace-related assets for external investment [1] - Zhibang Home intends to repurchase company shares worth between 80 million to 110 million yuan [3] Group 2: Investment Projects - Jiangsu Longsheng Weirui plans to invest approximately 350 million yuan to establish an intelligent robot innovation center [1] - Hainan Development's Zhuhai Sanxin plans to invest in the second phase of its production base project in Zhuhai [2] - New Fengming intends to invest 280 million USD to build a 360,000 tons/year functional fiber project in Egypt [2] Group 3: Contracts and Bids - Dayu Irrigation has pre-won the construction project for high-standard farmland in Inner Mongolia's Chifeng City for 2025 [1] - Dayu Irrigation has also pre-won the construction project for high-standard farmland in Inner Mongolia's Tongliao City for 2025 [2] - *ST Zhisheng has won the bid for the smart city governance (Phase IV) project [1] Group 4: Equity Transactions - Rongzi Technology plans to acquire 54.9688% of Guizhou Xinren's shares for 342 million yuan and will also increase its capital [3] - Tiankang Biological intends to purchase 51% equity of Qiangdu Livestock [2] - Binhai Energy plans to acquire 51% equity of Xingtai New Energy [3] Group 5: Share Buybacks and Holdings - Maide Medical plans to spend between 20 million to 40 million yuan to repurchase shares [3] - Tianli Technology's Qian Yongyao intends to reduce his holdings by no more than 3% [3] - Haichuan Intelligent's Wu Guifang and Zheng Xuefen plan to collectively reduce their holdings by no more than 5.98% [3] Group 6: Fundraising Activities - Tianshun Wind Power plans to raise no more than 1.95 billion yuan through a private placement [3] - Leisai Intelligent plans to raise no more than 1.144 billion yuan through a private placement [3]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688310 证券简称：迈得医疗 公告编号：2025-051 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 回购股份金额：不低于人民币2,000万元（含），不超过人民币4,000万元（含） ● 回购股份资金来源：公司首次公开发行股票超募资金或自有资金 ● 回购股份用途：用于减少公司注册资本 ● 回购股份价格：不超过人民币24元/股（含）。该价格不高于公司董事会通过回购股份决议前30个交 易日公司股票交易均价的150% ● 回购股份方式：集中竞价交易方式 ● 回购股份期限：自公司股东会审议通过本次回购股份方案之日起12个月内 ● 相关股东是否存在减持计划：公司董事、高级管理人员、控股股东、实际控制人及其一致行动人、回 购提议人、持股5%以上股东在未来3个月、未来6个月暂无减持公司股份的计划。若上述人员未来拟实 施股份减持计划，公司将按相关规定及时履行信息披露义务 本次回购股份方案尚需提交公司股东会审议。公司将于2025年12月30日召开2025 ...

北京商报讯（记者 丁宁）12月12日晚间，迈得医疗（688310）发布公告称，基于对公司未来发展的信 心和对公司价值的认可，为有效维护广大股东利益，增强投资者信心，在综合考虑公司财务状况以及未 来盈利能力的情况下，公司拟进行本次回购股份，用于减少公司注册资本。回购股份金额不低于2000万 元（含），不超过4000万元（含）。 ...

Group 1 - Moer Thread plans to use up to 7.5 billion yuan of idle raised funds for cash management, with a usage period of 12 months [1] - O-film plans to purchase 8.46% equity of its subsidiary Anhui Che Lian for a total of 3.64 billion yuan, increasing its ownership from 78.54% to 87% [2] - ST Lian Shi applies to revoke the delisting risk warning as its restructuring plan has been completed [3] Group 2 - Weirli signs a strategic cooperation framework agreement with Primech Holdings to build an industrial robot cooperation platform [4] - Race Intelligent plans to raise no more than 1.144 billion yuan through a private placement for core components of intelligent equipment [5] - Renfu Pharmaceutical's stock will be subject to other risk warnings and will be suspended for one day starting December 15 [6] Group 3 - Yongding Co. clarifies that its subsidiary Dongbu Superconductor does not directly manufacture controllable nuclear fusion devices [7] - Rongbai Technology plans to acquire part of Guizhou Xinren's equity and increase its capital to achieve control [9] - ST Hu Ke is under investigation by the Securities Regulatory Commission for suspected information disclosure violations [10] Group 4 - Yunnan Ge Industry plans to establish a subsidiary focused on organic germanium-related products [11] - Greenme intends to acquire 16.38% equity of Henan Recycling Group for 400 million yuan [12] - Jiangzhong Pharmaceutical plans to change its name to China Resources Jiangzhong Pharmaceutical [13] Group 5 - Jiangsu Guoxin's subsidiary Ma Zhou Power has completed the trial operation of a 1,000 MW coal-fired power generation unit [16] - Longsheng Technology plans to invest in a center for embodied intelligent robots [18] - Guangzhou Development has received approval for the registration of 8 billion yuan medium-term notes and 6 billion yuan short-term financing notes [19] Group 6 - China Merchants Port reported a container throughput of 17.248 million TEUs in November, a year-on-year increase of 6.4% [20] - Tianma Technology reported a total eel output of approximately 11,415.87 tons from January to November [21] Group 7 - Xilong Science plans to reduce its stake by up to 1% [22] - Xicet Testing's actual controller plans to transfer 5% of the company's shares [23] - Oppein Home's actual controller plans to increase its stake by 50 million to 100 million yuan [24] Group 8 - Maide Medical plans to repurchase shares worth 20 million to 40 million yuan [25] - Baicheng Pharmaceutical's major shareholder increased its stake by 0.85% [26] - Mengbaihe's major shareholder plans to reduce its stake by up to 1% [27] Group 9 - Xian Dao Ji Dian's shareholder has reduced its stake by 1.70% [28] - Yaxiang Integration's shareholder reduced its stake by 41,400 shares [29] - Zhiwei Intelligent's actual controller has reduced its stake, bringing the total holding to 69% [30] Group 10 - Jincheng Co.'s actual controller plans to reduce its stake by up to 0.97% [31] - Jianghua Micro's chairman has reduced his stake by 1.09% [32] - COSCO Shipping Energy signed a shipbuilding contract worth 7.882 billion yuan [33] Group 11 - Dayu Water Saving's subsidiary is expected to win two high-standard farmland construction projects [34] - Guorui Technology's subsidiary is a candidate for the GXLF project [36] - ST Zhisheng has won a smart city governance project worth 104 million yuan [37]

回购资金来源为公司首次公开发行股票超募资金或自有资金，所回购的股份将全部用于减少公司注册资 本。回购期限自股东会审议通过回购方案之日起12个月内。 据公告，以回购价格上限测算，本次预计回购股份数量约为83.33万股至166.67万股，占公司总股本的比 例约为0.50%至1.00%。 2025年前三季度，公司实现营业总收入2.25亿元，同比增长2.31%；归母净利润883.67万元，同比增长 15.82%。 核校：杨宁 截至2025年9月30日（未经审计），公司总资产11.98亿元，归属于上市公司股东的净资产8.06亿元，流 动资产7.29亿元。按照本次回购资金上限测算，分别占上述财务数据的3.34%、4.96%、5.49%。公司资 产负债率为29.86%，对公司偿债能力不会产生重大影响。 迈得医疗主营业务是医用耗材智能装备的研发、生产、销售和服务，有效整合医疗器械产品工艺、自动 化、软件等方面的技术，形成独特的产品与服务优势，为医用耗材生产企业提供自动化成套设备和软件 服务整体式解决方案。公司的主要产品包括安全输注类、血液净化类等两大类设备。 ...